tiprankstipranks
Solesence (SLSN)
NASDAQ:SLSN
US Market
Want to see SLSN full AI Analyst Report?

Solesence (SLSN) Price & Analysis

45 Followers

SLSN Stock Chart & Stats

$2.17
--
Market closed
$2.17
--

Bulls Say, Bears Say

Bulls Say
Gross Margin Improvement And Operational GainsA 300bp gross margin improvement reflects structural cost and productivity gains (labor efficiency, waste elimination). Management also set a 30% gross‑profit floor for 2026, indicating durable focus on margin cadence that can sustainably boost operating leverage and resiliency if execution continues.
Large Shipped + Open Orders BacklogA $47M shipped + open orders book provides multi‑quarter revenue visibility and supports capacity planning. This backlog reduces short‑term top‑line volatility, enables smoother production scheduling, and underpins revenue conversion assumptions that strengthen medium‑term cash flow predictability if supply execution stabilizes.
Proprietary Product Launches And AdjacenciesNew proprietary technologies expand differentiated offerings and open adjacencies (e.g., hair/scalp care, SPF hybrids). Product innovation and IP breadth improve stickiness with brand partners, support premium positioning, and diversify addressable markets—durable drivers of revenue growth and margin expansion over time.
Bears Say
Weak Cash Generation And Negative FCFVery limited operating cash and materially negative free cash flow constrain the company’s ability to fund working capital, invest in production scale, or absorb shocks without external capital. Persistently weak cash generation raises refinancing and liquidity risk and limits strategic optionality over the medium term.
Compressed Profitability Vs Prior YearSharp margin compression and slight top‑line decline indicate the business is less resilient to cost shocks and demand volatility. Reduced profitability undermines internal cash generation, limits reinvestment capacity, and raises execution pressure to deliver operational initiatives to restore sustainable earnings power.
Elevated Leverage Despite StabilizationAlthough leverage improved meaningfully, a >1x debt/equity profile remains elevated for a consumer ingredients business. Higher leverage reduces balance sheet flexibility, increases interest and refinancing exposure, and limits ability to pursue inorganic growth or absorb protracted execution delays without pressuring liquidity.

Solesence News

SLSN FAQ

What was Solesence’s price range in the past 12 months?
Solesence lowest stock price was $0.78 and its highest was $5.63 in the past 12 months.
    What is Solesence’s market cap?
    Solesence’s market cap is $79.11M.
      When is Solesence’s upcoming earnings report date?
      Solesence’s upcoming earnings report date is Aug 18, 2026 which is in 68 days.
        How were Solesence’s earnings last quarter?
        Currently, no data Available
        Is Solesence overvalued?
        According to Wall Street analysts Solesence’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Solesence pay dividends?
          Solesence does not currently pay dividends.
          What is Solesence’s EPS estimate?
          Solesence’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Solesence have?
          Solesence has 70,632,450 shares outstanding.
            What happened to Solesence’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Solesence?
            Currently, no hedge funds are holding shares in SLSN
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Solesence Stock Smart Score

              2
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Solesence

              Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.

              Solesence (SLSN) Earnings & Revenues

              SLSN Company Deck

              SLSN Earnings Call

              Q1 2026
              0:00 / 0:00
              Earnings Call Sentiment|Neutral
              The call presents a mixed but constructive picture: near-term financial results were pressured by shipment delays and investments tied to the Transform and Transcend initiative (revenue down ~11%, net loss and negative adjusted EBITDA), but key positives include a 300-basis-point gross margin improvement to 26%, a $47M shipped + open orders book, new proprietary technology launches (Chromalum and WHSPR), completed co-marketing activations with brand partners, and a clear operational roadmap (SIOP, shift changes, facility consolidation) with reiterated guidance including a 30% gross profit floor and a plan to return to double-digit EBITDA margins by year-end. Given the balance of material execution risks and encouraging operational and commercial progress, the tone is cautiously optimistic but transitional.View all SLSN earnings summaries
              Similar Stocks
              Company
              Price & Change
              Follow
              Helen Of Troy
              Nu Skin
              Edgewell Personal Care
              Beauty Health

              Ownership Overview

              5.91%2.03%0.05%89.95%
              0.05% Other Institutional Investors
              89.95% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks